(Q34677062)

3 August 2017

Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy (English)

1 reference

3 August 2017

Shawn Bugden

5

0 references

David Henry

object named as

David Henry

1

0 references

Gary F Teare

6

object named as

Gary Teare

1 reference

3 August 2017

8

Anick Bérard

1 reference

3 August 2017

Colin Dormuth

2

1 reference

3 August 2017

Brandace Winquist

3

1 reference

3 August 2017

Greg Carney

4

1 reference

3 August 2017

Linda E Lévesque

7

1 reference

3 August 2017

J Michael Paterson

9

1 reference

3 August 2017

Robert W Platt

10

1 reference

3 August 2017

CNODES (Canadian Network for Observational Drug Effect Studies) Investigators

11

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 April 2016

1 reference

Canadian Medical Association Journal

3 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

188

1 reference

3 August 2017

10

1 reference

3 August 2017

723-730

1 reference

Pregnancy and isotretinoin therapy

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Algorithms to estimate the beginning of pregnancy in administrative databases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Retinoic acid embryopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Availability of oral isotretinoin and terbinafine on the Internet.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Fetal exposure to isotretinoin-an international problem

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Continued occurrence of Accutane-exposed pregnancies

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4938682

Teratogenicity of isotretinoin

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27114489

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27114489

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1503/CMAJ.151243

1 reference

3 August 2017

1 reference

3 August 2017

1 reference